MicroTransponder

A medical technology company based in Texas, specializing in neuromodulation therapies. MicroTransponder Inc. has developed the Paired Vagus Nerve Stimulation (Paired VNS™) Platform, with its Vivistim® System being the first FDA-approved device for treating post-stroke upper limb impairment. The company's innovations primarily benefit stroke survivors seeking to improve motor function and regain independence.